Knowhow offering
|
| Title | Continuous integrated platform for the manufacturing of Trastuzumab Biosimilar |
| Knowhow is available for | Continuous integrated platform for the manufacturing of Trastuzumab Biosimilar |
| Summary | |
| Advantages | 1. Novel use of CFIR (coiled flow inverter reactor) for continuous viral clearance
2. Novel continuous processing platform that results in reduction in cost of manufacturing by 70% for clinical and 35% for commercial production
|
|
Knowhow is listed under following categories
|
Knowhow from
| |
| Scientific/ engineering subject areas |
Life sciences/ biosciences & engineering |
| Investor interest categories |
Biotechnology/ Biomedical/ Health Technologies |
| Industries |
Pharmaceuticals, Bulk Drugs, Formulations ; |
